Leaderboard

En | De
No articles selected!     View Cart  
You are here: Dermatology » Skin Neoplasms » Melanoma 24. May 2026
Search
medline.ch
Melanoma
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Melanoma
Others
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2284  Previews Next
   
   Articles 1 - 20 / 45663  
   
Spatial transcriptomics reveals influence of microenvironment on intrinsic fates in melanoma therapy resistance.
Genome Biol
Boe RH, Triandafillou CG, Lazcano R, Wargo JA, Raj A.
PMID: 42174697 [PubMed - as supplied by publisher]


HMGA1 promotes the proliferation, migration, and invasion of uveal melanoma cells via the PI3K/Akt/MMP-9 pathway.
BMC Med Genomics
Ren W, Luo B.
PMID: 42174595 [PubMed - as supplied by publisher]


Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score.
BMC Cancer
Pacaci B, Erkan Ozmarasali B, Deligonul A, Gurbuz AF, Karakurt Eryilmaz M, Atas Ipek S, Sariyar Busery N, Yilmaz E, Tunc MA, Guren AK, Kocaaslan E, Demirel A, Akagunduz F, Demircan NC, Kostek O.
PMID: 42174513 [PubMed - as supplied by publisher]


Phase 1/2 study of pegenzileukin, a pegylated recombinant non-alpha IL-2, with cemiplimab for the treatment of advanced unresectable or metastatic skin cancers.
J Immunother Cancer
Rojas C, Mortier L, Park JJ, Matamala L, Baakili A, Rao S, Xu J, Andrieu L, Wang R, Wang H, Paehler T, Abbadessa G, Ascierto PA.
PMID: 42173654 [PubMed - indexed for MEDLINE]


A cross-sectional analysis of low-cost non-cancer registry recruitment sources for a hybrid type 2 trial evaluating a digital intervention for melanoma survivors.
Mhealth
Schaefer A, Manne SL, Heckman CJ, Frederick S, Solleder J, Lu SE.
PMID: 42170224 [PubMed]


Frozen melanoma tissues yield extracellular vesicles with preserved diagnostic and immunogenic properties.
BMC Med
D Arrigo D, Park KS, Lässer C, Sigalas GP, Symonds E, Urzí O, Locatelli C, Olofsson Bagge R, Lötvall J, Crescitelli R.
PMID: 42169004 [PubMed - indexed for MEDLINE]


Efficacy of intraoperative topical Sapylin (OK-432) for preventing lymph leakage following inguinal lymph node dissection in melanoma: a retrospective cohort study.
BMC Surg
Ning K, Shi G, Xie X, Yuan Z, Wu Z.
PMID: 42168952 [PubMed - as supplied by publisher]


Meta-analytic microbiome target discovery for immune checkpoint inhibitor response in advanced melanoma.
Commun Med (Lond)
Zhang X, Mallick H, Rahnavard A.
PMID: 42168704 [PubMed]


Nivolumab and ipilimumab combination therapy for melanoma efficacy, safety and clinical integration in metastatic and adjuvant settings.
Discov Oncol
Afuh R, Ashinze P, Banerjee S, Egbunu E, Olaniyan MO, Ayo-Ige AB, Soyinka EK, Atere AO, Igwe S, Oladipupo YM, Obaoye A, Nasiru Y, Aboderin C, Olowookere S.
PMID: 42168665 [PubMed - as supplied by publisher]


Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial.
Nat Commun
Lee RJ, Rothwell DG, Smith N, Chow S, Delgado-SanMartin J, Mistry H, Sylvestre Y, Chiang SC, Clarke H, Gremel G, Gupta A, Hockenhull K, Kelso N, Kochhar R, Mullan D, Plummer R, Serra P, Shaw H, Summersgill H, Turajlic S, Mouliere F, Marais R, Dive C, Lorigan P.
PMID: 42168180 [PubMed - as supplied by publisher]


Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects.
J Pharmacol Exp Ther
Hsu CY, Rizaev J, AlAbdulhadi SAS, Abbas Al-Khafaji ZK, Gupta PK, Samikan KR, Sahoo S, Bainsal N.
PMID: 42167125 [PubMed - as supplied by publisher]


Skin Cancer: Management of Cutaneous Melanoma.
FP Essent
Nelson M MD, FAAFP, Hamel RK MD, Nash J MD.
PMID: 42166765 [PubMed - indexed for MEDLINE]


Skin Cancer: Diagnosis.
FP Essent
Nelson M MD, FAAFP, Hamel RK MD, Nash J MD.
PMID: 42166763 [PubMed - indexed for MEDLINE]


Skin Cancer: Screening and Prevention.
FP Essent
Nelson M MD, FAAFP, Hamel RK MD, Nash J MD.
PMID: 42166762 [PubMed - indexed for MEDLINE]


Correction to: A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England from 2016 to 2021.
Br J Dermatol

PMID: 42166717 [PubMed - as supplied by publisher]


Pregnancy and risk of melanoma: a matched retrospective cohort study.
Melanoma Res
Block BR, Mehta J, Powers CM, Ungar J, Farabi Atak SB, Gulati N.
PMID: 42166631 [PubMed - as supplied by publisher]


Ultrasound imaging features of cervical lymph nodes with melanoma metastasis compared with benign cervical nodes.
Melanoma Res
Alizada S, Al Qudah H, Vu T, Stewart J, Shah K, Debnam JM, Sahu S, Salim HA, Msherghi A, Maniakas A, Zafereo ME, Goepfert RP, Wintermark M, Ahmed S.
PMID: 42166628 [PubMed - as supplied by publisher]


Malignant Melanoma Misdiagnosis in the Diabetic Foot. What Can We Learn From the Published Literature?
J Foot Ankle Res
Bristow IR, Reynolds ML, Young M.
PMID: 42165691 [PubMed - indexed for MEDLINE]


Association of XPD Gene Polymorphisms with Cutaneous Melanoma Risk: A Meta-Analysis and Trial Sequence Evaluation.
Cancer Invest
Farnoush N, Rahmani A, Khosravi-Mashizi M, Shiri A, Dastgheib SA, Barahman M, Shirinzadeh-Dastgiri A, Vakili-Ojarood M, Naseri A, Asadian F, Aghasipour M, Aghili K, Neamatzadeh H.
PMID: 42165380 [PubMed - as supplied by publisher]


Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review.
Hum Vaccin Immunother
Cohen JE, Mehmi I, Avner M, Moyers J, Hamid O.
PMID: 42163062 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 45663    Page 1 of 2284  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1